Results 281 to 290 of about 844,308 (381)

Valorization of fishing industry by‐products for biodiesel production: Unlocking the potential of residual fish oil

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract Fishing waste and its by‐products, whether naturally occurring or generated by the processing industry, represent a significant opportunity for producing high‐value products. These often discarded or underutilized residues can be converted into various valuable products through advanced processing technologies. Among the potential products are
Patrick da Silva Sousa, Francisco Simão Neto, Paulo Gonçalves de Sousa Junior, Francisco Izaias da Silva Aires, Calebe da Rocha Silva, Kaiany Moreira dos Santos, Viviane de Castro Bizerra, Maria Alexsandra Sousa Rios, José Cleiton Sousa dos Santos   +8 more
wiley   +1 more source

An experimental medicine protocol for exploring the haemodynamic effects of dual agonism at the glucagon‐like peptide‐1 and glucagon receptor in healthy subjects

British Journal of Clinical Pharmacology, EarlyView.
Aims Glucagon‐like peptide‐1 (GLP‐1) and glucagon dual receptor agonists are in clinical development for a range of metabolic conditions, including type 2 diabetes and obesity. The cardiovascular actions at these receptors are well studied, but less is known about their combination.
James Goodman, Victoria E. Parker, Carmel M. McEniery, Giovanni Di Stefano, Annette Hubsch, Evangelia Vamvaka, Jo Helmy, Fotini Kaloyirou, Navazh Jalaludeen, Peter Barker, Lutz Jermutus, Joseph Cheriyan, Philip Ambery, Ian B. Wilkinson   +13 more
wiley   +1 more source

Association of surrogate indices of insulin resistance with hypertension: a cross-sectional analysis from PERSIAN Dena cohort study (PDCS). [PDF]

Sci Rep
Hosseini A, Ebrahimzadehkour B, Jowshan MR.   +2 more
europepmc   +1 more source

Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state.

Arteriosclerosis and Thrombosis A Journal of Vascular Biology, 1992
J. R. Patsch, G. Miesenbock, T. Hopferwieser, V. Muhlberger, E. Knapp, J. Dunn, A. Gotto, W. Patsch   +7 more
semanticscholar   +1 more source

Pharmacokinetics, pharmacodynamics and safety of vutiglabridin after multiple oral administrations in healthy female and obese subjects

British Journal of Clinical Pharmacology, EarlyView.
Aims Vutiglabridin (HSG4112) is a novel drug under clinical development for antiobesity treatment. This study aimed to evaluate the pharmacokinetics (PKs) and safety of vutiglabridin after multiple oral administrations in healthy Korean female and obese subjects and explore short‐term pharmacodynamic (PD) responses.
Sooyoun Lee, Hyun Chul Kim, Young Ran Yoon, In‐Jin Jang, Sang‐Ku Yoo, Kyung‐Sang Yu   +5 more
wiley   +1 more source

Hypertriglyceridemia is a dose-dependent risk factor for type 2 diabetes mellitus: a systematic review and meta-analysis. [PDF]

Front Endocrinol (Lausanne)
Havelda L, Szalai EÁ, Obeidat M, Dobszai D, Veres DS, Kói T, Sipter E, Váncsa S, Hegyi PJ, Bucur M, Molnár A, Vámossy KL, Hegyi P, Szentesi A.   +13 more
europepmc   +1 more source

Effects of deleting Y2 receptors from hypothalamic NPY-expressing neurons on liver triglyceride content and expression of key proteins regulating energy metabolism in female and male NPYCre/+;Y2^lox/lox mice and wild type mice.

, 2015
Yan‐Chuan Shi, Shu Lin, Iris P.L. Wong, Paul A. Baldock, Aygul Aljanova, Ronaldo F. Enriquez, Lesley Castillo, Natalie F. Mitchell, Ji‐Ming Ye, Lei Zhang, Laurence Macia, Ernie Yulyaningsih, Amy Nguyen, Sabrina J. Riepler, Herbert Herzog, Amanda Sainsbury   +15 more
openalex   +2 more sources

Long‐term impact of Elexacaftor/Tezacaftor/ivacaftor on pulmonary, nutritional and metabolic outcomes in homozygous F508del cystic fibrosis patients: A real‐world cohort study

British Journal of Clinical Pharmacology, EarlyView.
Aim Elexacaftor/tezacaftor/ivacaftor (ETI) has markedly improved cystic fibrosis (CF) outcomes. However, its long‐term impact on nutrition, metabolism and liver health remains underexplored. We assessed 30‐month changes in pulmonary, nutritional, metabolic and inflammatory markers in people with CF (PwCF) homozygous for F508del.
Nicola Perrotta, Luigi Angelo Fiorito, Roberta Vescovo, Anna Virgilio, Giulia Amato, Giuseppe Cimino   +5 more
wiley   +1 more source

Effectiveness of Saroglitazar in MASLD Patients: A Prospective, Real-World Assessment of Liver and Metabolic Health. [PDF]

Endocrinol Diabetes Metab
Gupta M, Lachhwani H, Chandra KP, Awasthi R, Kumar D.   +4 more
europepmc   +1 more source